Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 -6.532M
March 31, 2026 -6.163M
December 31, 2025 -5.830M
September 30, 2025 -5.710M
June 30, 2025 -5.406M
March 31, 2025 -5.495M
December 31, 2024 -5.260M
September 30, 2024 -4.643M
June 30, 2024 -4.344M
March 31, 2024 -4.037M
December 31, 2023 -3.786M
September 30, 2023 -3.506M
June 30, 2023 -3.194M
March 31, 2023 -2.997M
December 31, 2022 -2.769M
September 30, 2022 -2.941M
June 30, 2022 -2.620M
March 31, 2022 -2.338M
December 31, 2021 -2.174M
September 30, 2021 -1.851M
June 30, 2021 -1.609M
March 31, 2021 -1.552M
December 31, 2020 -1.480M
September 30, 2020 -1.472M
June 30, 2020 -1.367M
Date Value
March 31, 2020 -1.145M
December 31, 2019 -0.9164M
September 30, 2019 -1.783M
June 30, 2019 -19.04M
March 31, 2019 -18.51M
December 31, 2018 -17.96M
September 30, 2018 -14.91M
June 30, 2018 -13.73M
March 31, 2018 -22.92M
December 31, 2017
September 30, 2017 -16.62M
June 30, 2017 -13.97M
March 31, 2017 -11.43M
December 31, 2016 -8.943M
September 30, 2016 -7.640M
June 30, 2016 -6.398M
March 31, 2016 -4.542M
December 31, 2015 -3.163M
September 30, 2015 -0.6813M
June 30, 2015 -0.6404M
March 31, 2015 -0.3222M
December 31, 2014 -2.023M
September 30, 2014 -1.456M
June 30, 2014 -1.251M
March 31, 2014 -1.023M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -24.52M
MedX Health Corp. -10.70M
VentriPoint Diagnostics Ltd. -4.117M
Theralase Technologies, Inc. 6.842M
Profound Medical Corp. 70.67M

Shareholders Equity (Quarterly) Related Metrics